Osteoporotic profiles in elderly patients with symptomatic lumbar spinal canal stenosis

Indian Journal of Orthopaedics

Volumn 46, Issue 3, 2012, Pages 279-284

  Lee, Byung Ho ^a   Moon, Seong Hwan ^a   Kim, Ho Joong ^a   Lee, Hwan Mo ^a   Kim, Tae Hwan ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Bone mineral density; bone turnover marker; hypovitaminosis D; lumbar spinal stenosis; osteoporosis

Indexed keywords

EID: 84862555313     PISSN: 00195413     EISSN: 19983727     Source Type: Journal    
DOI: 10.4103/0019-5413.96379     Document Type: Review

References (36)

1. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States 2005-2025. J Bone Miner Res 2007; 22: 465-75.
2. Haussler B, Gothe H, Gol D, Glaeske G, Pientka L, Felsenberg D. Epidemiology, treatment and costs of osteoporosis in Germany-the BoneEVA Study. Osteoporos Int 2007; 18:77-84.
3. Caliri A, De Filippis L, Bagnato GL, Bagnato GF. Osteoporotic fractures: Mortality and quality of life. Panminerva Med 2007; 49: 21-7.
4. Fierens J, Broos PL. Quality of life after hip fracture surgery in the elderly. Acta Chir Belg 2006; 106: 393-6.
5. Pande I, Scott DL, O'Neill TW, Pritchard C, Woolf AD, Davis MJ. Quality of life, morbidity, and mortality after low trauma hip fracture in men. Ann Rheum Dis 2006; 65: 87-92.
6. Davidson CW, Merrilees MJ, Wilkinson TJ, McKie JS, Gilchrist NL. Hip fracture mortality and morbiditycan we do better? N Z Med J 2001; 114: 329-32.
7. Kaptan H, Kasimcan O, Cakiroglu K, Ilhan MN, Kilic C. Lumbar spinal stenosis in elderly patients. Ann N Y Acad Sci 2007; 1100: 173-8.
8. Szpalski M, Gunzburg R. Lumbar spinal stenosis in the elderly: An overview. Eur Spine J 2003; 12 Suppl 2:S 170-5.
9. Delmas PD, van de Langerijt L, Watts NB, Eastell R, Genant H, Grauer A, et al. Underdiagnosis of vertebral fractures is a worldwide problem: The IMPACT study. J Bone Miner Res 2005; 20: 557-63.
10. Makinen TJ, Alm JJ, Laine H, Svedstrom E, Aro HT. The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement. Bone 2007; 40: 1041-7.
11. Verbiest H. The significance and principles of computerized axial tomography in idiopathic developmental stenosis of the bony lumbar vertebral canal. Spine (Phila Pa 1976)1979; 4: 369-78.
12. Skedros JG, Sybrowsky CL, Stoddard GJ. The osteoporosis self-assessment screening tool: A useful tool for the orthopaedic surgeon. J Bone Joint Surg Am 2007; 89: 765-72.
13. National Osteoporosis Foundation. Osteoporosis: Review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Executive summary. Osteoporos Int 1998; 8 Suppl 4:S 3-6.
14. Kellgren JH. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 32: 1951-7.
15. National Osteoporosis Foundation. Physician's Guide to Prevention and Treatment of Osteoporosis ed. Belle Mead, NJ: Excerpta Medica Inc; 1999.
16. Westesson PL, Lee RK, Ketkar MA, Lin EP. Underdiagnosis and undertreatment of osteoporosis. Lancet 2002; 360: 1891.
17. Sinigaglia L, Varenna M, Girasole G, Bianchi G. Epidemiology of osteoporosis in rheumatic diseases. Rheum Dis Clin North Am 2006; 32: 631-58.
18. Peshin R, Phelan M. A national survey to assess investigation and management protocols followed in dealing with steroid-induced osteoporosis. Clin Rheumatol 2007; 26: 1439-43.
19. Savani BN, Donohue T, Kozanas E, Shenoy A, Singh AK, Childs RW, et al. Increased risk of bone loss without fracture risk in long-term survivors after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13:517-20.
20. Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, et al. Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 2000; 85: 4118-24.
21. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 1999; 282: 1344-52.
22. Li EC, Davis LE. Zoledronic acid: A new parenteral bisphosphonate. Clin Ther 2003; 25: 2669-708.
23. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344: 1434-41.
24. Rabenda V, Manette C, Lemmens R, Mariani AM, Struvay N, Reginster JY. Prevalence and impact of osteoarthritis and osteoporosis on health-related quality of life among active subjects. Aging Clin Exp Res 2007; 19: 55-60.
25. Lee WS, Park HM, Bae DH. Prevalence of osteoporosis in korean women. J Korean Soc Menopause 2003; 9: 339-46.
26. Fahrleitner-Pammer A, Obernosterer A, Pilger E, Dobnig H, Dimai HP, Leb G, et al. Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease. Osteoporos Int 2005; 16: 319-24.
27. Kim HJ, Lee HM, Kim HS, Park JO, Moon ES, Park H, et al. Bone metabolism in postmenopausal women with lumbar spinal stenosis: Analysis of bone mineral density and bone turnover markers. Spine (Phila Pa 1976) 2008; 33:2435-9.
28. Kim HJ, Lee HM, Chun HJ, Kang KT, Kim HS, Park JO, et al. Restoration of bone turnover rate after decompression surgery in patients with symptomatic lumbar spinal stenosis: Preliminary report. Spine (Phila Pa 1976)2009; 34: E 635-9.
29. Lata PF, Elliott ME. Patient assessment in the diagnosis, prevention, and treatment of osteoporosis. Nutr Clin Pract 2007; 22: 261-75.
30. Prince RL. Calcium and vitamin D - for whom and when. Menopause Int 2007; 13: 35-7.
31. Shinchuk L, Holick MF. Vitamin d and rehabilitation: Improving functional outcomes. Nutr Clin Pract 2007; 22: 297-304.
32. Deane A, Constancio L, Fogelman I, Hampson G. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis. BMC Musculoskelet Disord 2007; 8: 3.
33. Fujita T, Nakamura S, Ohue M, Fujii Y, Miyauchi A, Takagi Y, et al. Postural stabilizing effect of alfacalcidol and active absorbable algal calcium (AAA Ca) compared with calcium carbonate assessed by computerized posturography. J Bone Miner Metab 2007; 25: 68-73
34. Boonen S, Bischoff-Ferrari HA, Cooper C, Lips P, Ljunggren O, Meunier PJ, et al. Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: A review of the evidence. Calcif Tissue Int 2006; 78: 257-70.
35. Gaugris S, Heaney RP, Boonen S, Kurth H, Bentkover JD, Sen SS. Vitamin D inadequacy among post-menopausal women: A systematic review. Qjm 2005; 98: 667-76.
36. Fain O. Musculoskeletal manifestations of scurvy. Joint Bone Spine 2005; 72: 124-8.